282 filings
Page 3 of 15
8-K
ri9jgzi88cz7g
3 Sep 21
Securities Purchase Agreement
9:15am
8-K
penwd5fzhozxmplujj3l
30 Jul 21
Entry into a Material Definitive Agreement
4:11pm
8-K
uaqlbig75
6 Jul 21
Securities Purchase Agreement
5:10pm
8-K
8j9c1tfp0snfl5cokqnw
14 May 21
Securities Purchase Agreement
9:00am
8-K
gdpyqg0i9ufqdz
6 May 21
Regulation FD Disclosure
9:00am
8-K
a3zx6ir mdt8ooik
3 May 21
Securities Purchase Agreement
5:17pm
8-K
410 gwgt4q8ww5bwp
5 Apr 21
Securities Purchase Agreement
5:14pm
8-K
p8peot51rky
19 Feb 21
Securities Purchase Agreement
3:34pm
8-K
wzn1 74d8kn41
20 Jan 21
Entry into a Material Definitive Agreement
4:05pm
8-K
n0o9zbawi0zsw4r gzj
5 Jan 21
RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
4:20pm
8-K
b63t9h5cm
14 Dec 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:10am
8-K
f56jnfj2
1 Dec 20
Entry into a Material Definitive Agreement
9:23am
8-K
ew3fv
25 Nov 20
Amendments to Articles of Incorporation or Bylaws
9:20am
8-K
hvw19brsko yf
12 Nov 20
Regulation FD Disclosure
9:00am
8-K
njyke
5 Oct 20
Entry into a Material Definitive Agreement
4:05pm
8-K
umi4xnux
25 Sep 20
RespireRx Pharmaceuticals Inc. Announces Appointment of David Dickason as Senior Vice President Pre-Clinical Product Development
5:16pm
8-K
3h8c5asab6p624bm2y9r
5 Aug 20
Patent License Agreement
12:00am
8-K
k3x0t02ena5
3 Aug 20
Equity Purchase Agreement
5:30pm
8-K
o8styizd
13 Jul 20
Entry into a Material Definitive Agreement
5:20pm
8-K
4bg7sy o6
7 Jul 20
Securities Purchase Agreement
5:01pm